Publikationsserver
Self-management training vs. neurofeedback interventions for attention deficit hyperactivity disorder: Results of a randomized controlled treatment study
Objectives: Neurofeedback (NF) and self-management training (SMT) may be viable treatment options for patients with attention deficit hyperactivity disorder (ADHD) if they alleviate core symptoms, enhance the patients’ selfconcept and improve their quality of life (QoL). Aim of the current study...
Պահպանված է:
| Հիմնական հեղինակներ: | , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | անգլերեն |
| Հրապարակվել է: |
Philipps-Universität Marburg
2023
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | PDF ամբողջական տեքստ |
| Ցուցիչներ: |
Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| Ամփոփում: | Objectives: Neurofeedback (NF) and self-management training (SMT) may
be viable treatment options for patients with attention deficit hyperactivity
disorder (ADHD) if they alleviate core symptoms, enhance the patients’ selfconcept
and improve their quality of life (QoL). Aim of the current study
is evaluating both interventions accordingly and to test whether specific
improvements in core symptoms lead to more general improvements in
self-concept and QoL.
Methods: In a psychotherapeutic outpatient clinic in Germany, a total of
N = 139 children with ADHD were screened for eligibility, of which 111
fulfilled inclusion criteria and participated in the study in accordance with
the CONSORT 2010 statement. These were randomly assigned to NF vs.
SMT interventions. Changes from pre- to post-intervention in core ADHD
symptoms relying on parent and teacher reports (CONNERS 3) and objective
tests (Qb-Test) as well as self-concept (interview with the children) and QoL
assessments (using the KINDL-R self-report) were compared between patients
receiving NF or SMT.
Results: Significant improvements in ADHD symptoms were achieved
similarly in both treatment groups, whilst QoL and self-concept
improved after SMT only.
Conclusion: This treatment study provides further evidence that SMT and
NF may reduce core symptoms, but SMT may also improve patients’ selfconcept
and QoL and may thus in its current form be the favorable treatment
option in naturalistic settings. However, several limitations of the current study implicate that further research is required before definitive conclusions and
recommendations for clinical practice can be given.
Clinical trial registration: [www.clinicaltrials.gov], identifier [NCT01879644]. |
|---|---|
| Նյութի նկարագրություն: | Gefördert durch den Open-Access-Publikationsfonds der UB Marburg. |
| Ֆիզիկական նկարագրություն: | 17 Seiten |
| DOI: | 10.3389/fpsyt.2022.969351 |